BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
90 results:

  • 1. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
    Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
    Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression.
    Zhao L; Huang J; Liu W; Su X; Zhao B; Wang X; He X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):179. PubMed ID: 38584230
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
    Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
    [No Abstract]    [Full Text] [Related]  

  • 4. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
    Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway.
    Wu J; Wu Y; Chen S; Guo Q; Shao Y; Liu C; Lin K; Wang S; Zhu J; Chen X; Ju X; Xia L; Wu X
    Oncogene; 2024 Mar; 43(12):866-883. PubMed ID: 38297082
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells.
    Chen W; Peng W; Wang R; Bai S; Cao M; Xiong S; Li Y; Yang Y; Liang J; Liu L; Yazdani HO; Zhao Y; Cheng B
    Cell Death Dis; 2024 Jan; 15(1):102. PubMed ID: 38291031
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
    Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
    Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
    Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
    J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
    Chen J; Hu Q; Zhou C; Jin D
    Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment.
    Zhang L; Qiu L; Xu S; Cheng X; Wu J; Wang Y; Gao W; Bao J; Yu H
    Toxicol In Vitro; 2023 Dec; 93():105669. PubMed ID: 37634662
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
    Terzolo M; Fassnacht M; Perotti P; Libé R; Kastelan D; Lacroix A; Arlt W; Haak HR; Loli P; Decoudier B; Lasolle H; Quinkler M; Haissaguerre M; Chabre O; Caron P; Stigliano A; Giordano R; Zatelli MC; Bancos I; Fragoso MCBV; Canu L; Luconi M; Puglisi S; Basile V; Reimondo G; Kroiss M; Megerle F; Hahner S; Kimpel O; Dusek T; Nölting S; Bourdeau I; Chortis V; Ettaieb MH; Cosentini D; Grisanti S; Baudin E; Berchialla P; Bovis F; Sormani MP; Bruzzi P; Beuschlein F; Bertherat J; Berruti A
    Lancet Diabetes Endocrinol; 2023 Oct; 11(10):720-730. PubMed ID: 37619579
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
    Guo Z; Guo L
    Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. EvIPqPCR, Target Circulating Tumorous Extracellular Vesicles for Detection of Pancreatic cancer.
    Rasuleva K; Jangili KP; Akinlalu A; Guo A; Borowicz P; Li CZ; Sun D
    Anal Chem; 2023 Jul; 95(27):10353-10361. PubMed ID: 37339258
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis.
    Nam M; Yang W; Kim HS; Park J; Park G; Kim S; Song S; Ock CY; Wang VG; Chuang JH; Chae YK
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279258
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.
    Wu F; He J; Deng Q; Chen J; Peng M; Xiao J; Zeng Y; Yi L; Li Z; Tian R; Jiang Z
    Biochem Biophys Res Commun; 2023 Jul; 664():108-116. PubMed ID: 37141638
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumour microenvironment in pheochromocytoma and paraganglioma.
    Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
    Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. sdhb immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
    Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway.
    Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
    J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.